822 related articles for article (PubMed ID: 30442276)
61. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
[TBL] [Abstract][Full Text] [Related]
62. Valuation of the EQ-5D-3L in Russia.
Omelyanovskiy V; Musina N; Ratushnyak S; Bezdenezhnykh T; Fediaeva V; Roudijk B; Purba FD
Qual Life Res; 2021 Jul; 30(7):1997-2007. PubMed ID: 33713323
[TBL] [Abstract][Full Text] [Related]
63. Feasibility of Proxy-Reported EQ-5D-3L-Y and Its Agreement in Self-reported EQ-5D-3L-Y for Patients With Adolescent Idiopathic Scoliosis.
Lin J; Wong CKH; Cheung PWH; Luo N; Cheung JPY
Spine (Phila Pa 1976); 2020 Jul; 45(13):E799-E807. PubMed ID: 32539293
[TBL] [Abstract][Full Text] [Related]
64. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
65. Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments.
Chen G; Flynn T; Stevens K; Brazier J; Huynh E; Sawyer M; Roberts R; Ratcliffe J
Value Health; 2015 Jun; 18(4):432-8. PubMed ID: 26091597
[TBL] [Abstract][Full Text] [Related]
66. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
[TBL] [Abstract][Full Text] [Related]
67. A Value Set for the EQ-5D-Y-3L in the Netherlands.
Roudijk B; Sajjad A; Essers B; Lipman S; Stalmeier P; Finch AP
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):193-203. PubMed ID: 36216977
[TBL] [Abstract][Full Text] [Related]
68. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D.
Wille N; Badia X; Bonsel G; Burström K; Cavrini G; Devlin N; Egmar AC; Greiner W; Gusi N; Herdman M; Jelsma J; Kind P; Scalone L; Ravens-Sieberer U
Qual Life Res; 2010 Aug; 19(6):875-86. PubMed ID: 20405245
[TBL] [Abstract][Full Text] [Related]
69. [Measurement Properties and Value Set of EuroQol Five-Dimensional Questionnaire-Youth Version].
Sun Y; Yang ZH; Zhang RY; Wang P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):722-732. PubMed ID: 36065708
[TBL] [Abstract][Full Text] [Related]
70. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
71. Health inequity assessment in Brazil: is EQ-5D-3L sensible enough to detect differences among distinct socioeconomic groups?
Tura BR; da Costa MR; Lordello S; Barros D; Souza Y; da Silva Santos M
Health Qual Life Outcomes; 2024 Feb; 22(1):22. PubMed ID: 38409033
[TBL] [Abstract][Full Text] [Related]
72. Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L.
Chemli J; Drira C; Felfel H; Roudijk B; Al Sayah F; Kouki M; Kooli A; Razgallah Khrouf M
Qual Life Res; 2021 May; 30(5):1445-1455. PubMed ID: 33447958
[TBL] [Abstract][Full Text] [Related]
73. Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study.
Reckers-Droog V; Karimi M; Lipman S; Verstraete J
Value Health; 2022 Jul; 25(7):1174-1184. PubMed ID: 35168891
[TBL] [Abstract][Full Text] [Related]
74. Think of the Children: A Discussion of the Rationale for and Implications of the Perspective Used for EQ-5D-Y Health State Valuation.
Lipman SA; Reckers-Droog VT; Kreimeier S
Value Health; 2021 Jul; 24(7):976-982. PubMed ID: 34243841
[TBL] [Abstract][Full Text] [Related]
75. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.
Jyani G; Sharma A; Prinja S; Kar SS; Trivedi M; Patro BK; Goyal A; Purba FD; Finch AP; Rajsekar K; Raman S; Stolk E; Kaur M
Value Health; 2022 Jul; 25(7):1218-1226. PubMed ID: 35779943
[TBL] [Abstract][Full Text] [Related]
76. EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.
Hernandez Alava M; Wailoo A; Grimm S; Pudney S; Gomes M; Sadique Z; Meads D; O'Dwyer J; Barton G; Irvine L
Value Health; 2018 Jan; 21(1):49-56. PubMed ID: 29304940
[TBL] [Abstract][Full Text] [Related]
77. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O
Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358
[TBL] [Abstract][Full Text] [Related]
78. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.
Oppe M; Devlin NJ; van Hout B; Krabbe PF; de Charro F
Value Health; 2014 Jun; 17(4):445-53. PubMed ID: 24969006
[TBL] [Abstract][Full Text] [Related]
79. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
[TBL] [Abstract][Full Text] [Related]
80. Inconsistencies in TTO and VAS values for EQ-5D health states.
Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
